These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14659906)

  • 1. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.
    Karlsson AC; Martin JN; Younger SR; Bredt BM; Epling L; Ronquillo R; Varma A; Deeks SG; McCune JM; Nixon DF; Sinclair E
    J Immunol Methods; 2003 Dec; 283(1-2):141-53. PubMed ID: 14659906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antigen-specific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques.
    Pahar B; Li J; Rourke T; Miller CJ; McChesney MB
    J Immunol Methods; 2003 Nov; 282(1-2):103-15. PubMed ID: 14604545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A; Krause S
    Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic comparison of methods to measure HIV-1 specific CD8 T cells.
    Sun Y; Iglesias E; Samri A; Kamkamidze G; Decoville T; Carcelain G; Autran B
    J Immunol Methods; 2003 Jan; 272(1-2):23-34. PubMed ID: 12505709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
    Eshofonie A; van der Loeff MS; Whittle H; Jaye A
    Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
    Whiteside TL; Zhao Y; Tsukishiro T; Elder EM; Gooding W; Baar J
    Clin Cancer Res; 2003 Feb; 9(2):641-9. PubMed ID: 12576430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.
    Keane NM; Price P; Stone SF; John M; Murray RJ; French MA
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1991-6. PubMed ID: 11153082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.
    Zavaglio F; Cassaniti I; d'Angelo P; Zelini P; Comolli G; Gregorini M; Rampino T; Del Frate L; Meloni F; Pellegrini C; Abelli M; Ticozzelli E; Lilleri D; Baldanti F
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.
    Maecker HT; Hassler J; Payne JK; Summers A; Comatas K; Ghanayem M; Morse MA; Clay TM; Lyerly HK; Bhatia S; Ghanekar SA; Maino VC; Delarosa C; Disis ML
    BMC Immunol; 2008 Mar; 9():9. PubMed ID: 18366814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.
    Abate D; Saldan A; Forner G; Tinto D; Bianchin A; Palù G
    J Virol Methods; 2014 Feb; 196():157-62. PubMed ID: 24216234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients.
    Zavaglio F; Rivela F; Cassaniti I; Arena F; Gabanti E; Asti AL; Lilleri D; Rampino T; Baldanti F; Gregorini M
    J Med Virol; 2023 Feb; 95(2):e28507. PubMed ID: 36655741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
    Larsson M; Jin X; Ramratnam B; Ogg GS; Engelmayer J; Demoitie MA; McMichael AJ; Cox WI; Steinman RM; Nixon D; Bhardwaj N
    AIDS; 1999 May; 13(7):767-77. PubMed ID: 10357375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases.
    Ott PA; Berner BR; Herzog BA; Guerkov R; Yonkers NL; Durinovic-Bello I; Tary-Lehmann M; Lehmann PV; Anthony DD
    J Immunol Methods; 2004 Feb; 285(2):223-35. PubMed ID: 14980436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay.
    Jennes W; Kestens L; Nixon DF; Shacklett BL
    J Immunol Methods; 2002 Dec; 270(1):99-108. PubMed ID: 12379342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining.
    Letsch A; Scheibenbogen C
    Methods; 2003 Oct; 31(2):143-9. PubMed ID: 12957572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-gamma production and IFN-gamma-secreting cells.
    Brice GT; Graber NL; Hoffman SL; Doolan DL
    J Immunol Methods; 2001 Nov; 257(1-2):55-69. PubMed ID: 11687239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
    Tang YB; Tang XP; Jin X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.